Literature DB >> 30919120

Funding orphan medicinal products beyond price: sustaining an ecosystem.

Oriol de Sola-Morales1.   

Abstract

Mesh：

Year:  2019        PMID： 30919120     DOI： 10.1007/s10198-019-01047-0

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  7 in total

1.  Regulatory watch: The orphan drug pipeline in Europe.

Authors:  Thomas Morel; André Lhoir; Eline Picavet; Segundo Mariz; Bruno Sepodes; Jordi Llinares; David Cassiman
Journal:  Nat Rev Drug Discov       Date:  2016-06-01       Impact factor: 84.694

Review 2.  Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases.

Authors:  Michael Schlander; Charalabos-Markos Dintsios; Afschin Gandjour
Journal:  Value Health       Date:  2017-11-27       Impact factor: 5.725

3.  How important is severity for the evaluation of health services: new evidence using the relative social willingness to pay instrument.

Authors:  Jeff Richardson; Angelo Iezzi; Aimee Maxwell
Journal:  Eur J Health Econ       Date:  2016-07-25

4.  Prioritizing treatment of rare diseases: a survey of preferences of Norwegian doctors.

Authors:  Arna S Desser
Journal:  Soc Sci Med       Date:  2013-06-26       Impact factor: 4.634

5.  Estimating the budget impact of orphan medicines in Europe: 2010 - 2020.

Authors:  Carina Schey; Tsveta Milanova; Adam Hutchings
Journal:  Orphanet J Rare Dis       Date:  2011-09-27       Impact factor: 4.123

6.  Communal Sharing and the Provision of Low-Volume High-Cost Health Services: Results of a Survey.

Authors:  Jeff Richardson; Angelo Iezzi; Gang Chen; Aimee Maxwell
Journal:  Pharmacoecon Open       Date:  2017-03

7.  Estimating the budget impact of orphan drugs in Sweden and France 2013-2020.

Authors:  Adam Hutchings; Carina Schey; Richard Dutton; Felix Achana; Karolina Antonov
Journal:  Orphanet J Rare Dis       Date:  2014-02-13       Impact factor: 4.123
  7 in total
  1 in total

Review 1.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.